Oculis Holding AG (OCS) Return on Capital Employed (2023 - 2026)
Oculis Holding AG (OCS) recorded quarterly Return on Capital Employed of 0.44% in Q1 2026, down 20.16% quarter-over-quarter from 0.56% in Q4 2025, and down 247515.0% on a YoY basis from N/an in Q1 2025.
Oculis Holding AG (OCS) Return on Capital Employed (2023 - 2026) Analysis & Trends
Oculis Holding AG's Return on Capital Employed history runs 4 years deep, the most recent figure standing at 0.44% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 247515.0% year-over-year to 0.44%; the TTM figure through Mar 2026 stood at 0.44% (down 247515.0% YoY), while the FY2025 annual figure was 0.88%, down 7.0% from the prior year.
- Return on Capital Employed was 0.44% for Q1 2026 at Oculis Holding AG, down from 0.56% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 3776.85% in Q4 2024 to a low of 0.44% in Q1 2026.
- Historically, Return on Capital Employed has averaged 923.32% across 4 years, with a median of 0.92% in 2024.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed surged 377600 bps in 2024, then sank 377630 bps in 2025.
- A 4-year view of Return on Capital Employed shows it stood at 0.85% in 2023, then surged by 445715 bps to 3776.85% in 2024, then sank by 100 bps to 0.56% in 2025, then dropped by 20 bps to 0.44% in 2026.
- The last three Return on Capital Employed figures came in at 0.44% (Q1 2026), 0.56% (Q4 2025), and 1986.39% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 450.31% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 51.73% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -107.40% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -50.43% |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | 0.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.44% |
| Dec 31, 2025 | 0.56% |
| Sep 30, 2025 | 1,986.39% |
| Jun 30, 2025 | 1,912.55% |
| Mar 31, 2025 | 2,475.59% |
| Dec 31, 2024 | 3,776.85% |
| Sep 30, 2024 | 0.63% |
| Jun 30, 2024 | 0.92% |
| Mar 31, 2024 | 0.99% |
| Dec 31, 2023 | 0.85% |
| Sep 30, 2023 | 0.81% |